Summary of "Ten Special Rectification Items for Site Arrangement and Rectification"
Release time:
2020-07-22
Summary of "Ten Special Rectification on Site Arrangement and Rectification"
Peak Pharmaceutical Factory Raw Material Workshop has implemented "Ten Special Rectification on Site Arrangement and Rectification" since 4# June 10 . The workshop has strictly implemented the relevant requirements. The site has improved significantly and our basic purpose has been achieved. The habits and work style of the post personnel have changed significantly, the on-site sorting, rectification and cleaning work has been carried out in an orderly manner, and the subjective initiative of the post personnel has been mobilized. These achievements are also the result of our managers' strict implementation of the regulations, which also tells us a truth: the vitality of the system lies in the implementation, the key lies in the real grasp, and it depends on strict management.
In the process of implementing the "Ten Special Rectifications for On-site Sorting and Rectifying", managers have different understandings of the standards and requirements for implementation, but we should recognize the current situation and objective reality of the entire team, and we must gradually Promote the improvement of on-site management. On-site management cannot set too high goals and standards at the beginning, which is not conducive to consensus building and does not conform to the general tone of steady progress. Our job is to move forward, but not "" ". Step by step, steady progress will reduce resistance and increase consensus. We should understand that it is difficult to take the first step in doing something, and the second step will be easier. Our current "Ten Special Rectifications for On-site Sorting and Rectifying" is not without requirements and standards, but relatively low, and we are constantly guiding and correcting during on-site inspections.
As for punishment, all our punishments are first greeted, demonstrated, and then punished. In the management process, we are taboo to use "to punish without teaching" and "to punish " .
At the same time, we should also realize that in the process of on-site management, the person in charge of each line should strengthen the daily inspection, guidance, correction, punishment and reward work, so as to implement the "Ten Special Rectification on-site Arrangement and Rectification" in place, while the weekly inspection of the workshop management team can only be an auxiliary means to grasp the second hurdle and solve some problems that the person in charge of each line cannot solve or not found, provide collective wisdom for the heads of the various lines.
In the process of "Ten Special Rectification of Site Arrangement and Rectification", managers should realize that only "Fast ", "Quasi " and "Hard " can implement the "Ten Special Rectification of Site Arrangement and Rectification", form strong execution and make obvious achievements in site management. Only when the management work is serious, can it save face and strictly implement the regulations, can the system be implemented in place. Therefore, we call on all managers in the workshop to update their management concepts, really grasp and strictly control the system, and finally realize the rule of law. (Liu Bin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page